Showing results (31-40 of 3,787) with videos related to
Sort By:
Pageof 379
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 29, 2009
How immunotherapy can enhance the response to other modalities and improve outcome and quality of lifeW M Liu, B Meyer, A G DalgleishDrugs & Aging|August 5, 2000
Prospects for vaccination in prostate cancerM J Perry, D Hroulda, A G DalgleishLancet (London, England)|April 7, 1990
HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4F Manca, J A Habeshaw, A G DalgleishPostgraduate Medical Journal|November 1, 1991
Coeliac disease presenting with cerebellar degenerationR A Hermaszewski, S Rigby, A G DalgleishClinical and Experimental Immunology|September 6, 2000
Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitroM Guckian, I Dransfield, P Hay, et al.Expert Opinion on Investigational Drugs|July 5, 2005
The role of herpes simplex virus thymidine kinase in the treatment of solid tumoursM J Perry, S M Todryk, A G DalgleishLancet (London, England)|October 10, 1987
Inhibition of HIV replication in vitro by fusidic acidV Faber, A G Dalgleish, A Newell, et al.Medical and Pediatric Oncology|January 1, 1984
Bleomycin pulmonary toxicity: its relationship to renal dysfunctionA G Dalgleish, R L Woods, J A LeviNeuropathology and Applied Neurobiology|July 1, 1987
Do human T-lymphotrophic viruses (HTLVs) and other enveloped viruses induce autoimmunity in multiple sclerosis?A G Dalgleish, J K Fazakerley, H E WebbClinical and Experimental Immunology|July 27, 2001
Inhibition of p38 MAP kinase during cellular activation results in IFN-gamma-dependent augmentation of IL-12 production by human monocytes/macrophagesJ B Marriott, I A Clarke, A G DalgleishPageof 379